Pacific Edge posts $14.5m loss as it awaits US Medicare decisions

Pacific Edge posts $14.5m loss as it awaits US Medicare decisions
Pacific Edge chief executive Peter Meintjes says as each day passes, he feels more confident about a favourable decision from Novitas. (Image: Supplied)
John Anthony
Dunedin-headquartered cancer diagnostics company Pacific Edge has posted a $14.5 million after-tax loss for the six months to September 30.The NZX and ASX-listed company said it was awaiting outcomes of several events that had the potential to renew growth in Cxbladder, its urine-based genomic biomarker test for the detection and surveillance of bladder cancer. The events include:Novitas, the Medicare Administrative Contractor (MAC) with responsibility for Pacific Edge’s US lab, making a favourable policy decision on a Local Coverage...

More Markets

Fonterra's ingredients chief on second Trump presidency
Primary Sector

Fonterra's ingredients chief on second Trump presidency

The incoming US President has threatened tariffs on all imports. 

NZ sharemarket down 0.3% on quiet day
Markets Market close

NZ sharemarket down 0.3% on quiet day

The S&P/NZX 50 Index closed at 13,088.31, down 42.12 points or 0.32%.

Graham Skellern 20 Jan 2025
City Developments wants the rest of MCK
Markets

City Developments wants the rest of MCK

It has offered $2.25 per share for the 24% stake.

Riley Kennedy 20 Jan 2025
NZ sharemarket up over 1.8% for the week
Markets Market Close

NZ sharemarket up over 1.8% for the week

The S&P/NZX 50 Index closed at 13,130.43, up 129.76 points or 1%.

Graham Skellern 17 Jan 2025